HEMODYNAMIC AND ECHOCARDIOGRAPHIC COMPARISON AT 1 YEAR OF THE LOTUS AND COREVALVE TRANSCATHETER AORTIC VALVES IN HIGH AND EXTREME SURGICAL RISK PATIENTS: AN ANALYSIS FROM THE REPRISE III RANDOMIZED CONTROLLED TRIAL

REPRISE III is a multicenter, randomized comparison of the novel mechanically-expanded (Lotus) and self-expanding (CoreValve; CV) TAVI devices. Lotus was superior for primary effectiveness and non-inferior for primary safety endpoints. A detailed analysis of the hemodynamics and paravalvular leak (